PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $238,000 | +3.0% | 30,933 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $231,000 | -22.7% | 30,933 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $299,000 | +16.3% | 30,933 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $257,000 | -1.5% | 30,933 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $261,000 | +5.7% | 30,933 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $247,000 | +88.5% | 30,933 | +82.5% | 0.00% | +100.0% |
| Q2 2013 | $131,000 | – | 16,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |